Skip to main content
. 2023 May 23;30(12):1838–1848. doi: 10.5551/jat.64000

Table 4. Multivariate analysis for the determinants of NMD stratified by kidney function.

eGFR ≥ 60 mL/min/1.73 m2 (N = 172) eGFR <60 mL/min/1.73 m2 (N = 111)
β p β p
Age –0.426 <0.001 0.056 0.635
Sex (male= 1, female= 0) –0.129 0.122 0.061 0.578
Body mass index –0.259 0.003 0.174 0.125
Systolic blood pressure –0.132 0.064 –0.153 0.153
Current smoker (yes= 1, no= 0) –0.005 0.944 –0.038 0.711
RAS inhibitors (yes= 1, no= 0) –0.005 0.944 0.102 0.331
Calcium channel blockers (yes= 1, no= 0) –0.141 0.076 –0.105 0.336
Insulin therapy (yes= 1, no= 0) –0.081 0.290 0.021 0.843
Serum calcium 0.061 0.377 0.030 0.779
Serum phosphate 0.053 0.501 0.040 0.727
HbA1c 0.082 0.307 0.007 0.947
LDL-cholesterol –0.060 0.450 0.176 0.140
Triglycerides –0.175 0.036 0.040 0.741
HDL-cholesterol –0.051 0.515 –0.053 0.656
FGF23 –0.237 0.001 –0.247 0.040
R2 (p) 0.306 (<0.001) 0.149 (0.356)

β, standardized regression coefficient by multiple regression analysis; R2, multiple coefficients of determination. Abbreviations are the same as Table 1.